Lee Stern
YOU?
Author Swipe
View article: The Impact of Rapid Weight Regain on Fight Outcomes in Bellator Mixed Martial Arts Athletes
The Impact of Rapid Weight Regain on Fight Outcomes in Bellator Mixed Martial Arts Athletes Open
These findings suggest that weight regain may not provide a competitive advantage in Bellator MMA athletes.
View article: PB2008: INCIDENCE OF DRUG-INDUCED MYELOSUPPRESSION AND ASSOCIATED ADVERSE EVENTS, QUALITY OF LIFE, AND MEDICAL RESOURCE USE IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
PB2008: INCIDENCE OF DRUG-INDUCED MYELOSUPPRESSION AND ASSOCIATED ADVERSE EVENTS, QUALITY OF LIFE, AND MEDICAL RESOURCE USE IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA Open
Topic: 10. Myelodysplastic syndromes - Clinical Background: Adverse events (AEs) associated with drug-induced myelosuppression are of substantial concern when treating patients with hematologic malignancies, especially with combination the…
View article: Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy Open
This analysis suggests that increasing utilization of rVIII-SingleChain in hemophilia A patients may lead to cost savings as a result of reduced consumption with uncompromised efficacy in bleed protection.
View article: Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe Hemophilia A in Italy
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe Hemophilia A in Italy Open
Introduction: rVIII-SingleChain, a recombinant factor VIII (rFVIII), has demonstrated safety and efficacy in patients with hemophilia A in clinical trials and real-world evidence. This analysis aimed to estimate the potential budget impact…
View article: Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy Open
rVIII-SingleChain, a recombinant factor VIII (rFVIII), has demonstrated safety and efficacy in patients with hemophilia A in clinical trials and real-world evidence. This analysis aimed to estimate the potential budget impact of increasing…
View article: Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population
Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population Open
Funding from Sanofi supported this study. Tong was an employee of ProUnlimited, under contract with Sanofi during the time of the study. Kitio-Dschassi was a Sanofi employee at time of the analysis. Meng, Casciano, Stern, and Gultyaev are …
View article: The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System
The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System Open
Hemostasis products, such as SURGICEL®, have been increasingly used across a wide variety of surgical procedures to mitigate bleeding-related risks and complications. This retrospective observational study described the utilization pattern…
View article: Clinical and Economic Consequences Associated with Cytomegalovirus Infection Among Allogeneic Hematopoietic Cell Transplant Patients
Clinical and Economic Consequences Associated with Cytomegalovirus Infection Among Allogeneic Hematopoietic Cell Transplant Patients Open
Cytomegalovirus (CMV) infection in allogeneic hematopoietic cell transplant (HCT) pts is associated with significant morbidity and mortality and presents a substantial clinical management challenge. This study assessed the health and healt…
View article: First-Year Incidence of Double-Stranded DNA Virus Infections Following Hematopoietic Cell Transplantation
First-Year Incidence of Double-Stranded DNA Virus Infections Following Hematopoietic Cell Transplantation Open
Immunosuppressants prescribed as part of managing graft-versus-host disease in hematopoietic cell transplantation (HCT) increase the risk of opportunistic infections. Fewer viable options are available to treat double-stranded DNA (dsDNA) …
View article: First-Year Incidence of Adenovirus Infections Following Allogeneic Hematopoietic Cell Transplants in a Pediatric Population
First-Year Incidence of Adenovirus Infections Following Allogeneic Hematopoietic Cell Transplants in a Pediatric Population Open
Disseminated adenovirus (AdV) infection is associated with high mortality rates in pediatric patients who have undergone hematopoietic cell transplantation (HCT); however, the incidence and predictors of disseminated AdV are not well descr…